Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.000
+0.160 (5.63%)
At close: Mar 9, 2026, 4:00 PM EDT
3.050
+0.050 (1.67%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $141.39 million as of March 9, 2026. Its market cap has increased by 56.56% in one year.
Market Cap
141.39M
Enterprise Value
83.53M
1-Year Change
56.56%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $141.39M, a decrease of -82.42%. That is a compound annual growth rate of -29.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 133.85M | 50.26% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 141.63M |
| MacroGenics | 141.07M |
| Artiva Biotherapeutics | 140.89M |
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Oramed Pharmaceuticals | 130.75M |
| Polaryx Therapeutics | 129.72M |
| Spero Therapeutics | 129.58M |